Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Singulair in Children With Recurrent Obstructive Bronchitis
NCT04613180Phase 4Unknown
- Sponsor
- Samarkand State Medical University
- Start
- Jan 2018
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of montelukast in Chronic Bronchitis, sponsored by Samarkand State Medical University. Primary endpoint: Effectiveness of oral administration of montelukast sodium at 24 months. Status: unknown.
02
Drugs
montelukast
03
Conditions
Chronic Bronchitis
Beyond the preview
Go deeper on NCT04613180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04613180.